16 results
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
10 Apr 24
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
7:02am
sales; (v) the impact of global business, political and macroeconomic conditions, cybersecurity events, instability in the banking system, and global
8-K
EX-99.1
NRIX
Nurix Therapeutics Inc
15 Feb 24
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
4:01pm
conditions, cybersecurity events, instability in the banking system, and global events, including regional conflicts around the world, on Nurix’s
424B5
6s6zyhr583ei4bfz2
11 Apr 24
Prospectus supplement for primary offering
4:06pm
424B5
h5km2qduo xa
12 Apr 24
Prospectus supplement for primary offering
5:10pm
DEF 14A
425z857zun5aa
25 Mar 21
Definitive proxy
6:03am
S-3ASR
EX-1.2
cmfy lvdr0a
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-1.1
q0dqo20vvia7z4eiox
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
- Prev
- 1
- Next